Kevin Alcock has a diverse work experience in various companies. In 2009, they started as a Director at Executive Consulting Services Limited. Kevin served as a Non Executive Director at RMI INVESTMENT MANAGERS GROUP from 2015 and still holds the position. Kevin also has held roles as a Non Executive Chairman at Sky Pharmaceuticals Group since 2012 and at Ninety One Alternative Investment (pty) Limited since 2016. Kevin became a Non Executive Director at Ninety One Assurance Limited in 2011 and at Silica in 2020. In 2018, they joined Ninety One Fund Managers Limited as a Non Executive Director until 2022. Currently, they are serving as a Non Executive Director at Ninety One UK Limited and Bushveld Minerals. Kevin also served as a Director at FutureCorp Limited from 2012 to 2020.
Kevin Alcock attended Oriel from 1976 to 1981, although it is not specified if they obtained a degree or studied any specific field during this time. From 1983 to 1985, they pursued a B Comm and CTA degree in Accounting, Statistics & Economics at the University of Cape Town.
Sign up to view 0 direct reports
Get started